PUMD.US ProUroCare Medical Inc
- Market cap
- USD 1.86K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2013.
Is PUMD.US undervalued?
Graham numberThe Graham number of ProUroCare Medical Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ProUroCare Medical Inc fundamental analysis
No fundamental analysis for ProUroCare Medical Inc yet.
ProUroCare Medical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ProUroCare Medical Inc
ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was f…
Full company profileProUroCare Medical Inc financial statements
2013 annualized: Fiscal year 2013 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2013, the balance sheet is the latest quarter. Figures change when the annual report is published.
ProUroCare Medical Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2009 | 2010 | 2011 | 2012 | 2013 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.95M | -2.11M | -1.54M | -1.23M | -1.12M |
| Net Income | -6.94M | -6.02M | -2.06M | -2.96M | -1.96M |
| Balance Sheet | |||||
| Total Assets | 1.09M | 575K | 240K | 235K | 584K |
| Total Liabilities | 5.42M | 2.20M | 2.98M | 4.05M | 4.73M |
| Shareholders' Equity | -4.33M | -1.63M | -2.74M | -3.81M | -4.14M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | |||||
| Operating Cash Flow | -3.15M | -2.16M | -838K | -1.12M | -492K |
| Capital Expenditure | 1.66K | 14.3K | 9.56K | 9.56K | 0.00 |
| Ratios | |||||
| ROA | -638.3% | -1,046.5% | -861.0% | -1,257.3% | -336.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROA
- Return on assets: net income divided by total assets.
ProUroCare Medical Inc dividends
ProUroCare Medical Inc has not paid dividends in the last 4 fiscal years.
Last stock split: 1:10 on Feb 14, 2008.
Who owns ProUroCare Medical Inc
Ownership data of ProUroCare Medical Inc is not available yet.
ProUroCare Medical Inc company profile
- Company name
- ProUroCare Medical Inc
- Ticker
- PUMD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2
- Fiscal year end
- December
- Address
- 6440 Flying Cloud Drive, Eden Prairie, MN, United States, 55344
- Phone
- 952-476-6021
- Website
- prourocare.com
About ProUroCare Medical Inc
ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
ProUroCare Medical Inc management
2- Mr. Benjamin BanksCEO & Director
- Mr. Alan G. ShulerChief Financial Officer and Secretary · born 1948